- Home
- UPLD vs CTSO Comparison
UPLD vs CTSO Comparison
Compare UPLD & CTSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UPLD
- CTSO
- Stock Information
- Founded
- UPLD 2010
- CTSO 1997
- Country
- UPLD United States
- CTSO United States
- Employees
- UPLD N/A
- CTSO N/A
- Industry
- UPLD Computer Software: Prepackaged Software
- CTSO Medical/Dental Instruments
- Sector
- UPLD Technology
- CTSO Health Care
- Exchange
- UPLD Nasdaq
- CTSO Nasdaq
- Market Cap
- UPLD 52.9M
- CTSO 45.3M
- IPO Year
- UPLD 2014
- CTSO N/A
- Fundamental
- Price
- UPLD $1.82
- CTSO $0.62
- Analyst Decision
- UPLD Strong Buy
- CTSO Buy
- Analyst Count
- UPLD 1
- CTSO 2
- Target Price
- UPLD $4.50
- CTSO $5.38
- AVG Volume (30 Days)
- UPLD 159.7K
- CTSO 114.8K
- Earning Date
- UPLD 11-06-2025
- CTSO 11-13-2025
- Dividend Yield
- UPLD N/A
- CTSO N/A
- EPS Growth
- UPLD N/A
- CTSO N/A
- EPS
- UPLD N/A
- CTSO N/A
- Revenue
- UPLD $235,591,000.00
- CTSO $36,979,520.00
- Revenue This Year
- UPLD N/A
- CTSO $11.93
- Revenue Next Year
- UPLD N/A
- CTSO $21.22
- P/E Ratio
- UPLD N/A
- CTSO N/A
- Revenue Growth
- UPLD N/A
- CTSO 20.75
- 52 Week Low
- UPLD $1.62
- CTSO $0.60
- 52 Week High
- UPLD $5.64
- CTSO $1.61
- Technical
- Relative Strength Index (RSI)
- UPLD 38.89
- CTSO 25.28
- Support Level
- UPLD $1.70
- CTSO $0.61
- Resistance Level
- UPLD $1.96
- CTSO $0.70
- Average True Range (ATR)
- UPLD 0.15
- CTSO 0.06
- MACD
- UPLD 0.00
- CTSO -0.01
- Stochastic Oscillator
- UPLD 37.74
- CTSO 10.14
About UPLD Upland Software Inc.
Upland Software Inc is a software company. It provides cloud-based software applications in three categories: Knowledge Management that provides solutions designed to help organizations capture, organize, and distribute information to employees and customers. Content Lifecycle and Workflow Automation offers solutions that support document management, compliance, and process efficiency across various industries. Digital Marketing solutions that provides tools for audience engagement, campaign management, and content distribution across digital channels.
About CTSO Cytosorbents Corporation
CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.